Chester County News and Community Website
PHILADELPHIA, PA — As vaccination gaps persist across the United States, GSK announced it has awarded $2 million in grants to 16 nonprofit organizations nationwide, backing community-driven efforts to boost …
GSK Unleashes $2M Grant Push to Battle Vaccine Gaps, Pledges More for 2026 Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) said the U.S. Food and Drug Administration has approved Exdensur, a twice-yearly biologic treatment for patients with severe asthma characterized by an eosinophilic …
FDA Clears GSK’s Twice-Yearly Asthma Drug, Signaling Shift in Biologic Care Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients …
GSK Wins FDA Approval for Blenrep Combo in Advanced Multiple Myeloma Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has unveiled a major update to its Vaccine Track platform, expanding the interactive public data tool to include vaccination trends across 387 U.S. …
GSK Expands Vaccine Track With Metro-Level Data to Advance Adult Immunization Insights Read More PHILADELPHIA, PA — GSK plc has announced its sponsorship of the 2025 National Senior Games as part of its Sideline RSV campaign, a nationwide health education initiative aimed at informing adults …
GSK Highlights RSV Awareness Through National Senior Games Partnership and New TV Special Read More PHILADELPHIA, PA — GSK plc recently received approval from the U.S. Food and Drug Administration (FDA) for a prefilled syringe version of SHINGRIX, the company’s vaccine for shingles (herpes zoster). The …
FDA Approves Prefilled Syringe for GSK’s Shingles Vaccine, Streamlining Immunization Process Read More PHILADELPHIA, PA — GSK plc has announced the start of shipments for its trivalent seasonal influenza vaccines, FLULAVAL and FLUARIX, to healthcare providers and pharmacies across the United States. The …
GSK Begins Shipping Flu Vaccines Ahead of 2025-26 Season Following FDA Approval Read More PHILADELPHIA, PA — The U.S. Food and Drug Administration (FDA) this week approved GSK‘s 200 mg/mL autoinjector of Benlysta (belimumab) for use in children aged five and older who are …
FDA Approves Benlysta Autoinjector for Pediatric Lupus Nephritis Treatment Read More PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has introduced the Linked by Lupus: Optimal Care Initiative, a new program designed to improve the lives of individuals affected by lupus, with …
GSK Launches Linked by Lupus Initiative to Advance Care and Support Read More PHILADELPHIA, PA — The U.S. Food and Drug Administration (FDA) has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with chronic obstructive pulmonary disease (COPD) with …
FDA Approves GSK’s Nucala for COPD Patients with Eosinophilic Phenotype Read More